Mail & Guardian
Mail & Guardian

Sanac

latest news & developments
To end Aids by 2043, the South African government says it could get a group of local pharmaceutical companies to make generic shots of lenacapavir from 2027 onwards. There is, however, a hitch. None of the companies that will be involved have a licence to make the jab. (Julia Koblitz/ Unsplash)
AARON MOTSOALEDI

SA wants to make its own six-monthly HIV prevention jabs by 2027. But there’s a hitch

None of the companies that will be involved have a licence from the inventor of Lenacapavir, Gilead Sciences, to make the jab

  • Mia Malan
9 min read
The Health and Human Rights Oral History Project’s video testimonies that capture three decades of health activism from around the world, might provide a blueprint for the next wave of HIV activism. (Bhekisisa)
AIDS DENIALISM
Video

Fighting for funds: A new era of HIV activism

Instead of the Aids denialism of decades past, it’s US funding cuts that could lead to up to 300 000 more HIV infections in the next four years. Activists like Sisonke Msimang…

  • Ida Jooste
9 min read
ANGELA MAKHOLWA

Q&A Sessions: Meet Thembisile Xulu, a doctor, hip-hop fan and mother

Dr Thembisile Xulu, the newly appointed chief executive of the Sanac Trust, tells Nicolene de Wee about a new plan to fight HIV, TB and STIs — and her hip-hop dance moves

  • Nicolene de Wee
6 min read
The concern raised is that it may have unanticipated effects. Do we know for certain what the effects on edited persons and their progeny will be? No. (Thomas Mukoya/Reuters)
HIV
Video

Are provinces ready to take the wheel of South Africa’s HIV response?

It’s been a steep learning curve for districts that sometimes don’t have the know-how — or the data — to write and track local plans.

  • Roxy de Villiers
5 min read
Polygamy: It ain’t what it used to be
AIDS

Zuma’s new Aids plan to include TB

President Jacob Zuma has presented a five-year plan to reduce new HIV and TB infections by 50%.

  • Staff Reporter
2 min read